Trial intelligence / Profile preview

Mylan Estradiol Cream vs Estrace in Atrophic Vaginitis

NCT02195986Phase 3Completed

Sponsor
Mylan
Start
Jun 2014
Primary completion
Dec 2014
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of estradiol topical in atrophic vaginitis (3 arms), sponsored by Mylan. Primary endpoint: Primary Endpoint (Vaginal Cytology + Vaginal pH) Equivalence and Comparison to Placebo at Day 8. Started Jun 2014; status: completed.

02

Drugs

estradiol topical
03

Conditions

atrophic vaginitis

Beyond the preview

Go deeper on NCT02195986.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02195986.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call